Amalgamated Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Amalgamated Bank’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,075	Closed	-$589K	–	1850
2019 Q3	$589K	Sell	6,075 -83	-1%	-$8.31K	0.01%	965
2019 Q2	$630K	Buy	6,158 +1,380	+29%	+$149K	0.01%	959
2019 Q1	$544K	Buy	+4,778	New	+$351K	0.01%	962
2018 Q3	–	Sell	-4,799	Closed	-$397K	–	1709
2018 Q2	$397K	Buy	4,799 +1,100	+30%	+$84.9K	0.01%	1152
2018 Q1	$246K	Buy	+3,699	New	+$214K	0.01%	1338
2017 Q4	–	Sell	-3,397	Closed	-$303K	–	1663
2017 Q3	$303K	Buy	+3,397	New	+$258K	0.01%	1207

Amalgamated Bank's ONCE Position: Q4 2019 in Review

Amalgamated Bank sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 6,075 shares — an estimated $589K sold.

Amalgamated Bank first reported a position in ONCE in Q3 2017 and held it in 6 quarters. The position peaked at $630K in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Amalgamated Bank reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Amalgamated Bank sold 6,075 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $589K.
Amalgamated Bank first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
Amalgamated Bank's Spark Therapeutics, Inc. Common Stock position peaked at $630K in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Amalgamated Bank's 13F filing for Q4 2019, filed 13 Feb 2020.